CJC-1295 DAC 5mg

CJC-1295 DAC 5mg

Understanding This Long-Acting GHRH Analog

For researchers comparing CJ 1295 DAC for sale listings, the defining feature of this compound is its Drug Affinity Complex (DAC) — a modification that sets it apart from standard GHRH peptides. Understanding what that modification does mechanistically is essential before evaluating any CJC 1295 DAC for sale offer.

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The DAC version includes a maleimidopropionyl linker that covalently binds to circulating albumin after administration, which extends its plasma presence considerably compared to non-DAC GHRH analogs.

Why the DAC Modification Matters

Once you understand the mechanism, most CJC 1295 DAC for sale searches start making more sense — the DAC variant behaves very differently from its shorter-acting counterpart.

• Albumin-binding linker extends plasma half-life to roughly 6–8 days
• Documented in early-phase research to sustain IGF-1 elevation for up to 11 days per administration
• Distinct pharmacokinetic profile compared to CJC-1295 without DAC (sometimes referenced as Mod GRF 1-29)
• Studied primarily in early-phase, non-pivotal trials — no completed Phase 2 or Phase 3 efficacy data exists

CJC-1295 With DAC vs. Without DAC

The comparison cjc 1295 with dac vs without dac comes up constantly in research discussions, and the distinction is mostly about duration and release pattern:

Researchers weighing cjc 1295 with dac vs without dac often note that the no-DAC form is preferred in studies aiming to preserve the body’s natural pulsatile GH rhythm, while the DAC form is used where sustained receptor exposure is the variable under investigation.

What to Check Before You Buy CJC-1295 DAC

If you’re planning to buy cjc 1295 dac, sourcing quality should be the first filter, not price. Key things to verify:

• Third-party Certificate of Analysis (CoA) confirming ≥98% purity
• Clear batch/lot traceability
• Lyophilized formulation with proper cold-chain shipping
• Explicit research-use-only labeling — CJC-1295 currently has no FDA-approved therapeutic indication

Finding CJC-1295 DAC Online

When comparing CJC 1295 DAC online, look past marketing claims and check the documentation a supplier actually provides. Reputable sources selling CJC-1295 DAC online will clearly state research-use intent and won’t make therapeutic or dosing claims for human use.

Current Regulatory Context

CJC-1295’s regulatory position has shifted recently. As of an April 2026 FDA bulk drug substance list update, the compound was removed from Category 2 (substances 503A pharmacies can’t compound) but was not added to Category 1 either — it currently sits in an unclassified gap pending review by the FDA’s Pharmacy Compounding Advisory Committee. CJC-1295 has no FDA-approved finished drug product for any indication and is also listed under the WADA Prohibited List (S2) for athletes subject to anti-doping testing.

Frequently Asked Questions

Is it legal to buy CJC 1295 DAC?
CJC 1295 DAC can be purchased from licensed suppliers for research purposes. It is not approved by the FDA for human therapeutic use, and any clinical application should only occur under the direction of a licensed prescriber where locally permitted.

What’s the practical difference in cjc 1295 with dac vs without dac?
The DAC version extends the compound’s activity from minutes/hours to roughly a week, due to albumin binding. This changes both the research application and the release pattern being studied.

Why do prices vary so much across CJC 1295 DAC online listings?
Purity verification, batch testing, and cold-chain shipping all add cost. Listings priced far below market rate often skip third-party testing — a red flag for research-grade sourcing.

Is CJC-1295 DAC the same product as CJC-1295 no-DAC?
No. They’re related but distinct molecules with different pharmacokinetics, sometimes causing labeling confusion across suppliers — the FDA itself has noted inconsistent naming conventions across DAC, no-DAC, free-base, and salt forms. globalsteroidscenter.com  GHRH Analog & Growth Peptide Collection

Research-Use Disclaimer

This product is intended strictly for laboratory and research use. It is not approved by the FDA for human consumption, therapeutic use, or self-administration. CJC-1295 DAC currently has no finished-drug FDA approval and sits in an unresolved compounding classification pending regulatory review. Any decision regarding clinical or off-label use should involve a licensed healthcare provider and comply with all applicable local laws. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.